<html>
    <head>
        <meta charset="utf-8">
        
            <script src="lib/bindings/utils.js"></script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 600px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             
             #loadingBar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width: 100%;
                 height: 600px;
                 background-color:rgba(200,200,200,0.8);
                 -webkit-transition: all 0.5s ease;
                 -moz-transition: all 0.5s ease;
                 -ms-transition: all 0.5s ease;
                 -o-transition: all 0.5s ease;
                 transition: all 0.5s ease;
                 opacity:1;
             }

             #bar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width:20px;
                 height:20px;
                 margin:auto auto auto auto;
                 border-radius:11px;
                 border:2px solid rgba(30,30,30,0.05);
                 background: rgb(0, 173, 246); /* Old browsers */
                 box-shadow: 2px 0px 4px rgba(0,0,0,0.4);
             }

             #border {
                 position:absolute;
                 top:10px;
                 left:10px;
                 width:500px;
                 height:23px;
                 margin:auto auto auto auto;
                 box-shadow: 0px 0px 4px rgba(0,0,0,0.2);
                 border-radius:10px;
             }

             #text {
                 position:absolute;
                 top:8px;
                 left:530px;
                 width:30px;
                 height:50px;
                 margin:auto auto auto auto;
                 font-size:22px;
                 color: #000000;
             }

             div.outerBorder {
                 position:relative;
                 top:400px;
                 width:600px;
                 height:44px;
                 margin:auto auto auto auto;
                 border:8px solid rgba(0,0,0,0.1);
                 background: rgb(252,252,252); /* Old browsers */
                 background: -moz-linear-gradient(top,  rgba(252,252,252,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */
                 background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(252,252,252,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */
                 background: -webkit-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */
                 background: -o-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */
                 background: -ms-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */
                 background: linear-gradient(to bottom,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* W3C */
                 filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#fcfcfc', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */
                 border-radius:72px;
                 box-shadow: 0px 0px 10px rgba(0,0,0,0.2);
             }
             

             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
            <div id="loadingBar">
              <div class="outerBorder">
                <div id="text">0%</div>
                <div id="border">
                  <div id="bar"></div>
                </div>
              </div>
            </div>
        
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"color": "#8c564b", "id": "new research using nanosensors to detect protein-to-protein interactions", "label": "new research using nanosensors to detect protein-to-protein interactions", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#2ca02c", "id": "protein-to-protein interactions", "label": "protein-to-protein interactions", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#1f77b4", "id": "lymphocytic leukemia", "label": "lymphocytic leukemia", "shape": "dot", "title": "Cancer Type"}, {"color": "#ff7f0e", "id": "cancer", "label": "cancer", "shape": "dot", "title": "Cancer"}, {"color": "#e377c2", "id": "nanosensors", "label": "nanosensors", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#9467bd", "id": "cells", "label": "cells", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#d62728", "id": "cell membrane", "label": "cell membrane", "shape": "dot", "title": "Tissue used for cancer diagnosis"}, {"color": "#1f77b4", "id": "ovarian cancer", "label": "ovarian cancer", "shape": "dot", "title": "Cancer Type"}, {"color": "#e377c2", "id": "3-D-nanopatterned microfluidic chip", "label": "3-D-nanopatterned microfluidic chip", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#d62728", "id": "plasma", "label": "plasma", "shape": "dot", "title": "Tissue used for cancer diagnosis"}, {"color": "#ff7f0e", "id": "notoriously hard to detect cancers", "label": "notoriously hard to detect cancers", "shape": "dot", "title": "Cancer"}, {"color": "#2ca02c", "id": "exosomes", "label": "exosomes", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#8c564b", "id": "filtering for exosomes", "label": "filtering for exosomes", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#9467bd", "id": "cancer cells", "label": "cancer cells", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#7f7f7f", "id": "3-D nanoporous herringbone structure", "label": "3-D nanoporous herringbone structure", "shape": "dot", "title": "Cancer Diagnosis Technology"}, {"color": "#8c564b", "id": "mass transfer", "label": "mass transfer", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#bcbd22", "id": "not mentioned", "label": "not mentioned", "shape": "dot", "title": "Drugs"}, {"color": "#bcbd22", "id": "approved, safe drugs", "label": "approved, safe drugs", "shape": "dot", "title": "Drugs"}, {"color": "#ff7f0e", "id": "anticancer properties", "label": "anticancer properties", "shape": "dot", "title": "Cancer"}, {"color": "#CCCCCC", "id": "a drug developed to treat one condition", "label": "a drug developed to treat one condition", "shape": "dot", "title": "Drug"}, {"color": "#ff7f0e", "id": "value in treating another", "label": "value in treating another", "shape": "dot", "title": "Cancer"}, {"color": "#CCCCCC", "id": "pain reliever aspirin", "label": "pain reliever aspirin", "shape": "dot", "title": "Drug"}, {"color": "#ff7f0e", "id": "prevents cardiovascular disease", "label": "prevents cardiovascular disease", "shape": "dot", "title": "Cancer"}, {"color": "#CCCCCC", "id": "researchers", "label": "researchers", "shape": "dot", "title": "Researchers"}, {"color": "#CCCCCC", "id": "thousands of drug compounds", "label": "thousands of drug compounds", "shape": "dot", "title": "Drug compounds"}, {"color": "#CCCCCC", "id": "nearly 50 approved drug compounds", "label": "nearly 50 approved drug compounds", "shape": "dot", "title": "Drug compounds"}, {"color": "#ff7f0e", "id": "cancer-fighting capabilities", "label": "cancer-fighting capabilities", "shape": "dot", "title": "Cancer"}, {"color": "#CCCCCC", "id": "Dr Todd Golub", "label": "Dr Todd Golub", "shape": "dot", "title": "Dr Todd Golub"}, {"color": "#ff7f0e", "id": "anticipation of finding even a single compound with anticancer properties", "label": "anticipation of finding even a single compound with anticancer properties", "shape": "dot", "title": "Cancer"}, {"color": "#CCCCCC", "id": "The Broad Institute", "label": "The Broad Institute", "shape": "dot", "title": "Broad Institute"}, {"color": "#CCCCCC", "id": "Drug Repurposing Hub", "label": "Drug Repurposing Hub", "shape": "dot", "title": "Drug Repurposing Hub"}, {"color": "#CCCCCC", "id": "Dr Steven Corsello", "label": "Dr Steven Corsello", "shape": "dot", "title": "Dr Steven Corsello"}, {"color": "#CCCCCC", "id": "4,518 drugs", "label": "4,518 drugs", "shape": "dot", "title": "Drug compounds"}, {"color": "#CCCCCC", "id": "578 human cancer cell lines", "label": "578 human cancer cell lines", "shape": "dot", "title": "Drug compounds"}, {"color": "#e377c2", "id": "Cancer Cell Line Encyclopedia", "label": "Cancer Cell Line Encyclopedia", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#CCCCCC", "id": "Dr Golub\u0027s lab", "label": "Dr Golub\u0027s lab", "shape": "dot", "title": "Dr Golub\u0027s lab"}, {"color": "#CCCCCC", "id": "PRISM", "label": "PRISM", "shape": "dot", "title": "Molecular method"}, {"color": "#d62728", "id": "DNA barcode", "label": "DNA barcode", "shape": "dot", "title": "Tissue used for cancer diagnosis"}, {"color": "#8c564b", "id": "pooling several cell lines in a single dish", "label": "pooling several cell lines in a single dish", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#CCCCCC", "id": "some compounds", "label": "some compounds", "shape": "dot", "title": "Compounds"}, {"color": "#CCCCCC", "id": "previously overlooked molecular targets", "label": "previously overlooked molecular targets", "shape": "dot", "title": "Molecular targets"}, {"color": "#CCCCCC", "id": "activating other proteins or stabilizing interactions between proteins", "label": "activating other proteins or stabilizing interactions between proteins", "shape": "dot", "title": "Proteins"}, {"color": "#CCCCCC", "id": "Tepoxalin", "label": "Tepoxalin", "shape": "dot", "title": "Tepoxalin"}, {"color": "#CCCCCC", "id": "unknown target", "label": "unknown target", "shape": "dot", "title": "Molecular target"}, {"color": "#CCCCCC", "id": "protein that otherwise strengthens cancer cells\u2019 chemotherapy resistance", "label": "protein that otherwise strengthens cancer cells\u2019 chemotherapy resistance", "shape": "dot", "title": "Protein"}, {"color": "#CCCCCC", "id": "approved for treating osteoarthritis in dogs", "label": "approved for treating osteoarthritis in dogs", "shape": "dot", "title": "Usage"}, {"color": "#CCCCCC", "id": "cell-based approach", "label": "cell-based approach", "shape": "dot", "title": "Cell-based approach"}, {"color": "#CCCCCC", "id": "surprising interactions", "label": "surprising interactions", "shape": "dot", "title": "Interactions"}, {"color": "#bcbd22", "id": "Drugs developed for treating diabetes", "label": "Drugs developed for treating diabetes", "shape": "dot", "title": "Drugs"}, {"color": "#ff7f0e", "id": "potential use in treating cancer", "label": "potential use in treating cancer", "shape": "dot", "title": "Cancer"}, {"color": "#bcbd22", "id": "Drugs reducing inflammation", "label": "Drugs reducing inflammation", "shape": "dot", "title": "Drugs"}, {"color": "#bcbd22", "id": "Drugs controlling alcohol use disorder", "label": "Drugs controlling alcohol use disorder", "shape": "dot", "title": "Drugs"}, {"color": "#CCCCCC", "id": "comprehensive listing of the mechanisms by which each cancer cell line operates", "label": "comprehensive listing of the mechanisms by which each cancer cell line operates", "shape": "dot", "title": "Mechanisms"}, {"color": "#CCCCCC", "id": "Disulfiram", "label": "Disulfiram", "shape": "dot", "title": "Disulfiram"}, {"color": "#CCCCCC", "id": "cell lines with mutations", "label": "cell lines with mutations", "shape": "dot", "title": "Cell lines"}, {"color": "#CCCCCC", "id": "known as Antabuse, a drug that can support the treatment of alcohol use disorder", "label": "known as Antabuse, a drug that can support the treatment of alcohol use disorder", "shape": "dot", "title": "Usage"}, {"color": "#CCCCCC", "id": "genomic features", "label": "genomic features", "shape": "dot", "title": "Genomic features"}, {"color": "#bcbd22", "id": "drugs", "label": "drugs", "shape": "dot", "title": "Drugs"}, {"color": "#2ca02c", "id": "genetic mutations that drive specific cancers, biomarkers that predict disease risk or how well a person will respond to a particular treatment", "label": "genetic mutations that drive specific cancers, biomarkers that predict disease risk or how well a person will respond to a particular treatment", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#17becf", "id": "new therapies that seek to target the specific cellular pathway being exploited by a cancer", "label": "new therapies that seek to target the specific cellular pathway being exploited by a cancer", "shape": "dot", "title": "New Research of Cancer Diagnosis Method"}, {"color": "#9467bd", "id": "rare tumors", "label": "rare tumors", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#CCCCCC", "id": "genetic mutations underpinning each tumor", "label": "genetic mutations underpinning each tumor", "shape": "dot", "title": "Genetic mutations"}, {"color": "#8c564b", "id": "a therapy that was either designed for a different cancer or was in the clinical trial stage", "label": "a therapy that was either designed for a different cancer or was in the clinical trial stage", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#e377c2", "id": "not specified in the text", "label": "not specified in the text", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#d62728", "id": "tumor tissue", "label": "tumor tissue", "shape": "dot", "title": "Tissue used for cancer diagnosis"}, {"color": "#7f7f7f", "id": "next-generation DNA sequencing", "label": "next-generation DNA sequencing", "shape": "dot", "title": "Cancer Diagnosis Technology"}, {"color": "#2ca02c", "id": "genetic mutations that drive specific cancers", "label": "genetic mutations that drive specific cancers", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#7f7f7f", "id": "genomic profiling", "label": "genomic profiling", "shape": "dot", "title": "Cancer Diagnosis Technology"}, {"color": "#2ca02c", "id": "genetic driver events", "label": "genetic driver events", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#7f7f7f", "id": "multi-omics profiling", "label": "multi-omics profiling", "shape": "dot", "title": "Cancer Diagnosis Technology"}, {"color": "#2ca02c", "id": "genetic makeup, gene expression, proteins, metabolism, and gut microflora", "label": "genetic makeup, gene expression, proteins, metabolism, and gut microflora", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#d62728", "id": "tumor tissue, blood, and other bodily fluids", "label": "tumor tissue, blood, and other bodily fluids", "shape": "dot", "title": "Tissue used for cancer diagnosis"}, {"color": "#7f7f7f", "id": "omics analyses", "label": "omics analyses", "shape": "dot", "title": "Cancer Diagnosis Technology"}, {"color": "#2ca02c", "id": "genetic and epigenetic changes, tumor microenvironment, and metabolic and immunological changes", "label": "genetic and epigenetic changes, tumor microenvironment, and metabolic and immunological changes", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#bcbd22", "id": "cancer drugs", "label": "cancer drugs", "shape": "dot", "title": "Drugs"}, {"color": "#8c564b", "id": "chemotherapy", "label": "chemotherapy", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#e377c2", "id": "treatments", "label": "treatments", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#2ca02c", "id": "macropinocytosis", "label": "macropinocytosis", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#9467bd", "id": "tumors", "label": "tumors", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#9467bd", "id": "tumor cells", "label": "tumor cells", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#9467bd", "id": "aggressive cancers", "label": "aggressive cancers", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#8c564b", "id": "macropinocytosis inhibitors", "label": "macropinocytosis inhibitors", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#17becf", "id": "new types of drugs", "label": "new types of drugs", "shape": "dot", "title": "New Research of Cancer Diagnosis Method"}, {"color": "#8c564b", "id": "biomarker selection", "label": "biomarker selection", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#ff7f0e", "id": "Prostate cancer", "label": "Prostate cancer", "shape": "dot", "title": "Cancer"}, {"color": "#8c564b", "id": "Digital rectal exams", "label": "Digital rectal exams", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#2ca02c", "id": "PSA (prostate-specific antigen)", "label": "PSA (prostate-specific antigen)", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#e377c2", "id": "Blood tests", "label": "Blood tests", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#8c564b", "id": "Blood tests for PSA", "label": "Blood tests for PSA", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#2ca02c", "id": "prostate urine risk (PUR) tests", "label": "prostate urine risk (PUR) tests", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#9467bd", "id": "Prostate", "label": "Prostate", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#d62728", "id": "Urine", "label": "Urine", "shape": "dot", "title": "Tissue used for cancer diagnosis"}, {"color": "#8c564b", "id": "At-home urine tests", "label": "At-home urine tests", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#e377c2", "id": "Urine sampling kits", "label": "Urine sampling kits", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#7f7f7f", "id": "BioTechniques (journal)", "label": "BioTechniques (journal)", "shape": "dot", "title": "Cancer Diagnosis Technology"}, {"color": "#bcbd22", "id": "Not specified", "label": "Not specified", "shape": "dot", "title": "Drugs"}, {"color": "#e377c2", "id": "Laboratory", "label": "Laboratory", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#bcbd22", "id": "Nilotinib", "label": "Nilotinib", "shape": "dot", "title": "Drugs"}, {"color": "#1f77b4", "id": "Leukemia", "label": "Leukemia", "shape": "dot", "title": "Cancer Type"}, {"color": "#CCCCCC", "id": "Parkinson\u0027s disease", "label": "Parkinson\u0027s disease", "shape": "dot", "title": "Parkinson\u0027s disease"}, {"color": "#CCCCCC", "id": "Clinical trial", "label": "Clinical trial", "shape": "dot", "title": "Clinical Trial"}, {"color": "#2ca02c", "id": "Biomarkers for tracking disease progress and the effectiveness of therapies", "label": "Biomarkers for tracking disease progress and the effectiveness of therapies", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#CCCCCC", "id": "Products of dopamine metabolism, alpha-synuclein, and tau", "label": "Products of dopamine metabolism, alpha-synuclein, and tau", "shape": "dot", "title": "Substance"}, {"color": "#CCCCCC", "id": "Motor and nonmotor Parkinson\u0027s symptoms", "label": "Motor and nonmotor Parkinson\u0027s symptoms", "shape": "dot", "title": "Symptoms"}, {"color": "#CCCCCC", "id": "Around 60,000 people receive a diagnosis of Parkinson\u0027s per year in the United States, where nearly 1 million are living with the disease. Parkinson\u0027s usually affects people after the age of 60 and is more common in males than females.", "label": "Around 60,000 people receive a diagnosis of Parkinson\u0027s per year in the United States, where nearly 1 million are living with the disease. Parkinson\u0027s usually affects people after the age of 60 and is more common in males than females.", "shape": "dot", "title": "Epidemiology"}, {"color": "#CCCCCC", "id": "Accumulation of badly-folded alpha-synuclein protein", "label": "Accumulation of badly-folded alpha-synuclein protein", "shape": "dot", "title": "Biological hallmark"}, {"color": "#CCCCCC", "id": "FDA", "label": "FDA", "shape": "dot", "title": "FDA"}, {"color": "#CCCCCC", "id": "Moussa and colleagues", "label": "Moussa and colleagues", "shape": "dot", "title": "Researchers"}, {"color": "#CCCCCC", "id": "Animal models of neurodegeneration", "label": "Animal models of neurodegeneration", "shape": "dot", "title": "Animal models"}, {"color": "#CCCCCC", "id": "Another study", "label": "Another study", "shape": "dot", "title": "Study"}, {"color": "#CCCCCC", "id": "Participants with moderately advanced Parkinson\u0027s disease", "label": "Participants with moderately advanced Parkinson\u0027s disease", "shape": "dot", "title": "Participants"}, {"color": "#CCCCCC", "id": "Three groups", "label": "Three groups", "shape": "dot", "title": "Groups"}, {"color": "#CCCCCC", "id": "150 milligrams (mg) and 300 mg of nilotinib per day", "label": "150 milligrams (mg) and 300 mg of nilotinib per day", "shape": "dot", "title": "Dosage"}, {"color": "#CCCCCC", "id": "Placebo", "label": "Placebo", "shape": "dot", "title": "Placebo"}, {"color": "#CCCCCC", "id": "12 months", "label": "12 months", "shape": "dot", "title": "Duration"}, {"color": "#CCCCCC", "id": "3 months", "label": "3 months", "shape": "dot", "title": "Washout period"}, {"color": "#CCCCCC", "id": "Double-blinding", "label": "Double-blinding", "shape": "dot", "title": "Blinding"}, {"color": "#CCCCCC", "id": "Results", "label": "Results", "shape": "dot", "title": "Results"}, {"color": "#CCCCCC", "id": "Reasonably safe", "label": "Reasonably safe", "shape": "dot", "title": "Safety"}, {"color": "#CCCCCC", "id": "More severe side effects", "label": "More severe side effects", "shape": "dot", "title": "Side effects"}, {"color": "#CCCCCC", "id": "Abl tyrosine kinase", "label": "Abl tyrosine kinase", "shape": "dot", "title": "Protein"}, {"color": "#CCCCCC", "id": "Black box warning", "label": "Black box warning", "shape": "dot", "title": "Warning"}, {"color": "#CCCCCC", "id": "Nilotinib does not seem to cause Abl inhibition", "label": "Nilotinib does not seem to cause Abl inhibition", "shape": "dot", "title": "Abl inhibition"}, {"color": "#CCCCCC", "id": "Lower levels of alpha-synuclein and tau", "label": "Lower levels of alpha-synuclein and tau", "shape": "dot", "title": "Biomarkers"}, {"color": "#CCCCCC", "id": "Higher levels of dopamine metabolites", "label": "Higher levels of dopamine metabolites", "shape": "dot", "title": "Dopamine metabolites"}, {"color": "#CCCCCC", "id": "Slowed progression", "label": "Slowed progression", "shape": "dot", "title": "Nonmotor symptoms"}, {"color": "#CCCCCC", "id": "Improvements", "label": "Improvements", "shape": "dot", "title": "Motor symptoms"}, {"color": "#CCCCCC", "id": "Fernando L. Pagan", "label": "Fernando L. Pagan", "shape": "dot", "title": "Researchers"}, {"color": "#CCCCCC", "id": "Translational Neurotherapeutics Program", "label": "Translational Neurotherapeutics Program", "shape": "dot", "title": "Program"}, {"color": "#CCCCCC", "id": "Higher scores", "label": "Higher scores", "shape": "dot", "title": "Quality of life measures"}, {"color": "#CCCCCC", "id": "Important observations", "label": "Important observations", "shape": "dot", "title": "Observations"}, {"color": "#1f77b4", "id": "acute myeloid leukemia (AML)", "label": "acute myeloid leukemia (AML)", "shape": "dot", "title": "Cancer Type"}, {"color": "#ff7f0e", "id": "AML", "label": "AML", "shape": "dot", "title": "Cancer"}, {"color": "#9467bd", "id": "bone marrow", "label": "bone marrow", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#9467bd", "id": "bloodstream", "label": "bloodstream", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#9467bd", "id": "liver, spleen, lymph system, testicles, brain, and spinal cord", "label": "liver, spleen, lymph system, testicles, brain, and spinal cord", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#2ca02c", "id": "MTF2", "label": "MTF2", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#8c564b", "id": "gene expression analysis", "label": "gene expression analysis", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#e377c2", "id": "samples taken from people with AML", "label": "samples taken from people with AML", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#7f7f7f", "id": "chemical tags placement", "label": "chemical tags placement", "shape": "dot", "title": "Cancer Diagnosis Technology"}, {"color": "#e377c2", "id": "mouse models of AML", "label": "mouse models of AML", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#bcbd22", "id": "MDM2 blockers", "label": "MDM2 blockers", "shape": "dot", "title": "Drugs"}, {"color": "#8c564b", "id": "cell death pathway", "label": "cell death pathway", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#d62728", "id": "chemoresistant AML cells from humans", "label": "chemoresistant AML cells from humans", "shape": "dot", "title": "Tissue used for cancer diagnosis"}, {"color": "#ff7f0e", "id": "N/A", "label": "N/A", "shape": "dot", "title": "Cancer"}, {"color": "#17becf", "id": "New research on e-cigarettes\u0027 health effects", "label": "New research on e-cigarettes\u0027 health effects", "shape": "dot", "title": "New Research of Cancer Diagnosis Method"}, {"color": "#bcbd22", "id": "Nicotine", "label": "Nicotine", "shape": "dot", "title": "Drugs"}, {"color": "#CCCCCC", "id": "Electronic Nicotine Delivery Systems (ENDS), e-cigarettes", "label": "Electronic Nicotine Delivery Systems (ENDS), e-cigarettes", "shape": "dot", "title": "Device/Tool for Cancer Diagnosis"}, {"color": "#CCCCCC", "id": "Aerosolization technology", "label": "Aerosolization technology", "shape": "dot", "title": "Technology for Cancer Diagnosis"}, {"color": "#9467bd", "id": "Heart", "label": "Heart", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#8c564b", "id": "Electrocardiogram (ECG)", "label": "Electrocardiogram (ECG)", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#2ca02c", "id": "Bradycardia, increased blood pressure, aldehydes", "label": "Bradycardia, increased blood pressure, aldehydes", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#d62728", "id": "ECG transmitters", "label": "ECG transmitters", "shape": "dot", "title": "Tissue used for cancer diagnosis"}, {"color": "#17becf", "id": "new research of cancer diagnosis method", "label": "new research of cancer diagnosis method", "shape": "dot", "title": "New Research of Cancer Diagnosis Method"}, {"color": "#CCCCCC", "id": "gluten-free diet", "label": "gluten-free diet", "shape": "dot", "title": "Gluten-free diet"}, {"color": "#d62728", "id": "tissue used for cancer diagnosis", "label": "tissue used for cancer diagnosis", "shape": "dot", "title": "Tissue used for cancer diagnosis"}, {"color": "#9467bd", "id": "tissue affected by cancer", "label": "tissue affected by cancer", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#2ca02c", "id": "biomarker for cancer diagnosis", "label": "biomarker for cancer diagnosis", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#8c564b", "id": "cancer diagnosis method", "label": "cancer diagnosis method", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#e377c2", "id": "cancer diagnosis device/tool", "label": "cancer diagnosis device/tool", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#7f7f7f", "id": "cancer diagnosis technology", "label": "cancer diagnosis technology", "shape": "dot", "title": "Cancer Diagnosis Technology"}, {"color": "#1f77b4", "id": "cancer type", "label": "cancer type", "shape": "dot", "title": "Cancer Type"}, {"color": "#CCCCCC", "id": "rice flour", "label": "rice flour", "shape": "dot", "title": "Rice flour"}, {"color": "#CCCCCC", "id": "arsenic", "label": "arsenic", "shape": "dot", "title": "Arsenic"}, {"color": "#CCCCCC", "id": "mercury", "label": "mercury", "shape": "dot", "title": "Mercury"}, {"color": "#ff7f0e", "id": "Cancer", "label": "Cancer", "shape": "dot", "title": "Cancer"}, {"color": "#8c564b", "id": "Immune reaction triggered by the body", "label": "Immune reaction triggered by the body", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#9467bd", "id": "Tissue affected by cancer", "label": "Tissue affected by cancer", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#2ca02c", "id": "C-reactive protein (CRP)", "label": "C-reactive protein (CRP)", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#CCCCCC", "id": "Cancer diagnosis", "label": "Cancer diagnosis", "shape": "dot", "title": "Cancer Diagnosis"}, {"color": "#bcbd22", "id": "Nonsteroidal anti-inflammatory drugs (NSAIDs)", "label": "Nonsteroidal anti-inflammatory drugs (NSAIDs)", "shape": "dot", "title": "Drugs"}, {"color": "#CCCCCC", "id": "Treatment for Inflammation", "label": "Treatment for Inflammation", "shape": "dot", "title": "Treatment for Inflammation"}, {"color": "#bcbd22", "id": "Corticosteroids", "label": "Corticosteroids", "shape": "dot", "title": "Drugs"}, {"color": "#bcbd22", "id": "Immunosuppressant drugs", "label": "Immunosuppressant drugs", "shape": "dot", "title": "Drugs"}, {"color": "#CCCCCC", "id": "Olive oil, high fiber foods, tomatoes, nuts, leafy greens, fatty fish, fruit", "label": "Olive oil, high fiber foods, tomatoes, nuts, leafy greens, fatty fish, fruit", "shape": "dot", "title": "Foods"}, {"color": "#CCCCCC", "id": "Anti-inflammatory diet", "label": "Anti-inflammatory diet", "shape": "dot", "title": "Diet"}, {"color": "#CCCCCC", "id": "Fried foods, highly processed foods, foods and drinks with added sugar, red meat, unhealthful fats", "label": "Fried foods, highly processed foods, foods and drinks with added sugar, red meat, unhealthful fats", "shape": "dot", "title": "Foods"}, {"color": "#CCCCCC", "id": "Diet that aggravates inflammation", "label": "Diet that aggravates inflammation", "shape": "dot", "title": "Diet"}, {"color": "#e377c2", "id": "smart toilet", "label": "smart toilet", "shape": "dot", "title": "Cancer Diagnosis Device/Tool"}, {"color": "#1f77b4", "id": "prostate cancer", "label": "prostate cancer", "shape": "dot", "title": "Cancer Type"}, {"color": "#8c564b", "id": "urinalysis strips", "label": "urinalysis strips", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#2ca02c", "id": "biomarkers", "label": "biomarkers", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#9467bd", "id": "urinary tract", "label": "urinary tract", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#d62728", "id": "feces, urine", "label": "feces, urine", "shape": "dot", "title": "Tissue used for cancer diagnosis"}, {"color": "#7f7f7f", "id": "machine learning algorithms", "label": "machine learning algorithms", "shape": "dot", "title": "Cancer Diagnosis Technology"}, {"color": "#8c564b", "id": "gauging the consistency of fecal matter from the images", "label": "gauging the consistency of fecal matter from the images", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#9467bd", "id": "gut, intestines", "label": "gut, intestines", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#2ca02c", "id": "chlorogenic acids", "label": "chlorogenic acids", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#2ca02c", "id": "caffeine", "label": "caffeine", "shape": "dot", "title": "Biomarker for Cancer Diagnosis"}, {"color": "#bcbd22", "id": "green coffee bean extract", "label": "green coffee bean extract", "shape": "dot", "title": "Drugs"}, {"color": "#9467bd", "id": "heart", "label": "heart", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#9467bd", "id": "liver", "label": "liver", "shape": "dot", "title": "Tissue affected by cancer"}, {"color": "#8c564b", "id": "chlorogenic acid", "label": "chlorogenic acid", "shape": "dot", "title": "Cancer Diagnosis Method"}, {"color": "#d62728", "id": "digestive tract", "label": "digestive tract", "shape": "dot", "title": "Tissue used for cancer diagnosis"}]);
                  edges = new vis.DataSet([{"from": "new research using nanosensors to detect protein-to-protein interactions", "title": "The new research uses nanosensors to detect protein-to-protein interactions which are being used as a biomarker for cancer diagnosis.", "to": "protein-to-protein interactions"}, {"from": "new research using nanosensors to detect protein-to-protein interactions", "title": "The new research using nanosensors to detect protein-to-protein interactions is particularly helpful for detecting lymphocytic leukemia, a form of cancer that starts in the bone marrow and spreads into the blood.", "to": "lymphocytic leukemia"}, {"from": "cancer", "title": "The text mentions that new research uses nanosensors to detect cancer.", "to": "nanosensors"}, {"from": "nanosensors", "title": "The nanosensors are used to detect protein-to-protein interactions in cells, which are affected by cancer.", "to": "cells"}, {"from": "nanosensors", "title": "The nanosensors create a small opening in the cell membrane through which electric current passes.", "to": "cell membrane"}, {"from": "ovarian cancer", "title": "The 3-D-nanopatterned microfluidic chip is a device used for diagnosing ovarian cancer.", "to": "3-D-nanopatterned microfluidic chip"}, {"from": "3-D-nanopatterned microfluidic chip", "title": "The 3-D-nanopatterned microfluidic chip uses plasma, a component of blood, for diagnosing cancer.", "to": "plasma"}, {"from": "notoriously hard to detect cancers", "title": "Ovarian cancer is an example of a hard-to-detect cancer.", "to": "ovarian cancer"}, {"from": "exosomes", "title": "The method of diagnosing cancer involves filtering for exosomes, which are biomarkers for cancer diagnosis.", "to": "filtering for exosomes"}, {"from": "filtering for exosomes", "title": "The method of filtering for exosomes identifies and diagnoses cancer by analyzing the exosomes produced by cancer cells.", "to": "cancer cells"}, {"from": "filtering for exosomes", "title": "The method of filtering for exosomes uses plasma, a component of blood, for diagnosing cancer.", "to": "plasma"}, {"from": "3-D nanoporous herringbone structure", "title": "The method of mass transfer in cancer diagnosis uses the 3D nanoporous herringbone structure technology.", "to": "mass transfer"}, {"from": "mass transfer", "title": "The method of mass transfer identifies and diagnoses cancer by analyzing the exosomes produced by cancer cells.", "to": "cancer cells"}, {"from": "mass transfer", "title": "The method of mass transfer uses plasma, a component of blood, for diagnosing cancer.", "to": "plasma"}, {"from": "not mentioned", "title": "The text does not mention any drugs or cancer diagnosis.", "to": "not mentioned"}, {"from": "approved, safe drugs", "title": "Some approved, safe drugs have unexpected anticancer properties.", "to": "anticancer properties"}, {"from": "a drug developed to treat one condition", "title": "Occasionally, researchers find that a drug developed to treat one condition has unexpected value in treating another.", "to": "value in treating another"}, {"from": "pain reliever aspirin", "title": "A well-known case in point is the pain reliever aspirin, which turns out to be of use in preventing cardiovascular disease.", "to": "prevents cardiovascular disease"}, {"from": "researchers", "title": "Researchers have taken a fresh look at thousands of drug compounds", "to": "thousands of drug compounds"}, {"from": "nearly 50 approved drug compounds", "title": "The investigation concludes that nearly 50 approved drug compounds have previously unrecognized cancer-fighting capabilities.", "to": "cancer-fighting capabilities"}, {"from": "Dr Todd Golub", "title": "He is the senior investigator of the study, which is summarized in the journal Nature Cancer. He says, \u2018We thought we\u2019d be lucky if we found even a single compound with anticancer properties\u0027", "to": "anticipation of finding even a single compound with anticancer properties"}, {"from": "The Broad Institute", "title": "The Broad Institute\u2019s Drug Repurposing Hub is a massive database designed to help researchers find new uses for already approved compounds.", "to": "Drug Repurposing Hub"}, {"from": "Dr Steven Corsello", "title": "The first author of the study, Dr Steven Corsello, the founder of the hub and an oncologist at Dana-Farber, says", "to": "Drug Repurposing Hub"}, {"from": "researchers", "title": "The researchers tested 4,518 drugs", "to": "4,518 drugs"}, {"from": "578 human cancer cell lines", "title": "The researchers tested 4,518 drugs on 578 human cancer cell lines from the Broad Institute\u2019s Cancer Cell Line Encyclopedia.", "to": "Cancer Cell Line Encyclopedia"}, {"from": "Dr Golub\u0027s lab", "title": "Dr Golub\u2019s lab had developed a molecular method called PRISM", "to": "PRISM"}, {"from": "PRISM", "title": "Dr Golub\u2019s lab had developed a molecular method called PRISM that tags each cell line with a DNA barcode", "to": "DNA barcode"}, {"from": "DNA barcode", "title": "The barcodes sped up the testing by allowing the researchers to pool several cell lines in a single dish without losing the ability to track the survival rate of each as it reacted to a drug compound.", "to": "pooling several cell lines in a single dish"}, {"from": "some compounds", "title": "The ways in which some compounds fought the cancer cells were surprising", "to": "cancer cells"}, {"from": "some compounds", "title": "Most of these mechanisms involved interacting with previously overlooked molecular targets in the cancer cells.", "to": "previously overlooked molecular targets"}, {"from": "some compounds", "title": "For example, some of the drugs did not inhibit proteins in cancer cells as expected, but instead fought the cancer by activating other proteins or stabilizing interactions between proteins.", "to": "activating other proteins or stabilizing interactions between proteins"}, {"from": "Tepoxalin", "title": "Tepoxalin, an anti-inflammatory compound, interacted with an unknown target", "to": "unknown target"}, {"from": "Tepoxalin", "title": "Tepoxalin interacted with an unknown target to weaken the expression of a protein that otherwise strengthens cancer cells\u2019 chemotherapy resistance.", "to": "protein that otherwise strengthens cancer cells\u2019 chemotherapy resistance"}, {"from": "Tepoxalin", "title": "This compound was originally intended for use in humans but is currently approved for treating osteoarthritis in dogs.", "to": "approved for treating osteoarthritis in dogs"}, {"from": "cell-based approach", "title": "The cell-based approach was able to expose these surprising interactions more readily than other research methods.", "to": "surprising interactions"}, {"from": "Drugs developed for treating diabetes", "title": "Drugs developed for treating diabetes were among those had potential use in treating cancer", "to": "potential use in treating cancer"}, {"from": "Drugs reducing inflammation", "title": "Drugs reducing inflammation were among those had potential use in treating cancer", "to": "potential use in treating cancer"}, {"from": "Drugs controlling alcohol use disorder", "title": "Drugs controlling alcohol use disorder were among those had potential use in treating cancer", "to": "potential use in treating cancer"}, {"from": "Cancer Cell Line Encyclopedia", "title": "The cell line encyclopedia\u2019s comprehensive listing of the mechanisms by which each cancer cell line operates enabled the team to predict which compounds could combat the lines most effectively.", "to": "comprehensive listing of the mechanisms by which each cancer cell line operates"}, {"from": "Disulfiram", "title": "Disulfiram attacked cell lines with mutations that depleted specific proteins called metallothioneins.", "to": "cell lines with mutations"}, {"from": "Disulfiram", "title": "One hope is that, going forward, each cell line\u2019s cancer-causing mechanisms can serve as biomarkers, and that researchers will determine which drugs are especially good at targeting them. For example, disulfiram \u2014 also known as Antabuse, a drug that can support the treatment of alcohol use disorder \u2014 attacked cell lines with mutations that depleted specific proteins called metallothioneins.", "to": "known as Antabuse, a drug that can support the treatment of alcohol use disorder"}, {"from": "genomic features", "title": "The genomic features gave us some initial hypotheses about how the drugs could be acting, which we can then take back to study in the lab. Our understanding of how these drugs kill cancer cells gives us a starting point for developing new therapies.", "to": "drugs"}, {"from": "cancer", "title": "Biomarkers, such as genetic mutations that drive specific cancers and biomarkers that predict disease risk or how well a person will respond to a particular treatment, are used in cancer diagnosis.", "to": "genetic mutations that drive specific cancers, biomarkers that predict disease risk or how well a person will respond to a particular treatment"}, {"from": "cancer", "title": "New therapies are being developed to target the specific cellular pathway being exploited by a cancer, contributing to advances in cancer diagnosis.", "to": "new therapies that seek to target the specific cellular pathway being exploited by a cancer"}, {"from": "cancer", "title": "Rare tumors are a type of cancer that occurs in fewer than 15 patients per 100,000 each year, and they are the focus of a study by Dr. Shumei Kato.", "to": "rare tumors"}, {"from": "rare tumors", "title": "The study by Dr. Shumei Kato aimed to identify the genetic mutations underpinning each rare tumor.", "to": "genetic mutations underpinning each tumor"}, {"from": "genetic mutations underpinning each tumor", "title": "The genetic mutations underpinning each tumor were used to match 37 of the 40 study participants to a therapy that was either designed for a different cancer or was in the clinical trial stage.", "to": "a therapy that was either designed for a different cancer or was in the clinical trial stage"}, {"from": "a therapy that was either designed for a different cancer or was in the clinical trial stage", "title": "A therapy that was either designed for a different cancer or was in the clinical trial stage was used as a cancer diagnosis method, but the specific device or tool is not mentioned in the text.", "to": "not specified in the text"}, {"from": "a therapy that was either designed for a different cancer or was in the clinical trial stage", "title": "The cancer diagnosis method involved using tumor tissue to identify genetic mutations underpinning each tumor.", "to": "tumor tissue"}, {"from": "new therapies that seek to target the specific cellular pathway being exploited by a cancer", "title": "New therapies that seek to target the specific cellular pathway being exploited by a cancer are being developed, but the specific device or tool is not mentioned in the text.", "to": "not specified in the text"}, {"from": "new therapies that seek to target the specific cellular pathway being exploited by a cancer", "title": "New therapies that seek to target the specific cellular pathway being exploited by a cancer use tumor tissue to identify the cellular pathway.", "to": "tumor tissue"}, {"from": "next-generation DNA sequencing", "title": "Next-generation DNA sequencing is used to identify genetic mutations that drive specific cancers, which are biomarkers for cancer diagnosis.", "to": "genetic mutations that drive specific cancers"}, {"from": "genomic profiling", "title": "Genomic profiling is used to identify genetic driver events, which are biomarkers for cancer diagnosis.", "to": "genetic driver events"}, {"from": "multi-omics profiling", "title": "Multi-omics profiling is used to analyze an individual\u2019s genetic makeup, gene expression, proteins, metabolism, and gut microflora, which are biomarkers for cancer diagnosis.", "to": "genetic makeup, gene expression, proteins, metabolism, and gut microflora"}, {"from": "multi-omics profiling", "title": "Multi-omics profiling is used to analyze tumor tissue, blood, and other bodily fluids to identify biomarkers for cancer diagnosis.", "to": "tumor tissue, blood, and other bodily fluids"}, {"from": "multi-omics profiling", "title": "Multi-omics profiling is used to analyze an individual\u2019s genetic makeup, gene expression, proteins, metabolism, and gut microflora, but the specific drugs are not mentioned in the text.", "to": "not specified in the text"}, {"from": "omics analyses", "title": "A combination of omics analyses is used to identify genetic and epigenetic changes, tumor microenvironment, and metabolic and immunological changes, which are biomarkers for cancer diagnosis.", "to": "genetic and epigenetic changes, tumor microenvironment, and metabolic and immunological changes"}, {"from": "omics analyses", "title": "Omics analyses are used to analyze tumor tissue to identify genetic and epigenetic changes, tumor microenvironment, and metabolic and immunological changes.", "to": "tumor tissue"}, {"from": "omics analyses", "title": "Omics analyses are used to identify genetic and epigenetic changes, tumor microenvironment, and metabolic and immunological changes, but the specific drugs are not mentioned in the text.", "to": "not specified in the text"}, {"from": "cancer", "title": "The text mentions that cancer becomes resistant to certain cancer drugs.", "to": "cancer drugs"}, {"from": "cancer", "title": "The text mentions that cancers will often respond to chemotherapy drugs initially.", "to": "chemotherapy"}, {"from": "cancer", "title": "The text mentions that treatments are used for cancer.", "to": "treatments"}, {"from": "cancer", "title": "The text describes macropinocytosis as a mechanism that allows cancer cells to consume other dead cells, which gives them the energy and nutrients they need to grow.", "to": "macropinocytosis"}, {"from": "cancer", "title": "The text mentions that tumors can develop resistance to cancer drugs.", "to": "tumors"}, {"from": "cancer", "title": "The text mentions that tumor cells become resistant to cancer drugs.", "to": "tumor cells"}, {"from": "cancer", "title": "The text mentions that aggressive cancers are more likely to develop resistance to cancer drugs.", "to": "aggressive cancers"}, {"from": "chemotherapy", "title": "The text mentions that macropinocytosis inhibitors have the potential to produce significant gains in survival in patients with lethal, aggressive cancers when used in combination with radiation and standard-of-care chemotherapy.", "to": "macropinocytosis inhibitors"}, {"from": "macropinocytosis inhibitors", "title": "The text mentions that the authors hope their findings will help in the development of new types of drugs that will inhibit macropinocytosis.", "to": "new types of drugs"}, {"from": "macropinocytosis inhibitors", "title": "The text describes macropinocytosis as a mechanism that allows cancer cells to consume other dead cells, which gives them the energy and nutrients they need to grow, and mentions that macropinocytosis inhibitors have the potential to produce significant gains in survival in patients with lethal, aggressive cancers when used in combination with radiation and standard-of-care chemotherapy.", "to": "macropinocytosis"}, {"from": "biomarker selection", "title": "The text mentions that this knowledge could enable better biomarker selection in clinical drug trials currently underway, leading to an improved response to pharmaceutical combinations.", "to": "new types of drugs"}, {"from": "Prostate cancer", "title": "Prostate cancer is commonly diagnosed using digital rectal exams.", "to": "Digital rectal exams"}, {"from": "Prostate cancer", "title": "PSA is a biomarker used for the diagnosis of prostate cancer.", "to": "PSA (prostate-specific antigen)"}, {"from": "PSA (prostate-specific antigen)", "title": "PSA blood tests are used to measure the levels of PSA, a biomarker for prostate cancer diagnosis.", "to": "Blood tests"}, {"from": "Prostate cancer", "title": "Prostate cancer can be diagnosed using blood tests for PSA.", "to": "Blood tests for PSA"}, {"from": "Prostate cancer", "title": "PUR tests are used to detect clues about the presence of prostate cancer.", "to": "prostate urine risk (PUR) tests"}, {"from": "Prostate", "title": "Urine is used for prostate cancer diagnosis as it carries cancer cells and RNA from the prostate.", "to": "Urine"}, {"from": "At-home urine tests", "title": "At-home urine tests for prostate cancer diagnosis use urine sampling kits.", "to": "Urine sampling kits"}, {"from": "At-home urine tests", "title": "At-home urine tests for prostate cancer diagnosis use urine samples.", "to": "Urine"}, {"from": "At-home urine tests", "title": "The findings of the at-home urine tests for prostate cancer diagnosis were published in the BioTechniques journal.", "to": "BioTechniques (journal)"}, {"from": "At-home urine tests", "title": "There is no mention of drugs being used in the at-home urine tests for prostate cancer diagnosis.", "to": "Not specified"}, {"from": "At-home urine tests", "title": "At-home urine tests for prostate cancer diagnosis involve mailing urine samples to the laboratory.", "to": "Laboratory"}, {"from": "Digital rectal exams", "title": "Digital rectal exams encourage cellular and genetic material to move from the prostate.", "to": "Prostate"}, {"from": "Digital rectal exams", "title": "Digital rectal exams increase the levels of biomarkers in urine for prostate cancer diagnosis.", "to": "Urine"}, {"from": "Nilotinib", "title": "Nilotinib is a drug that regulators have approved for the treatment of leukemia.", "to": "Leukemia"}, {"from": "Nilotinib", "title": "Nilotinib has shown promise in a clinical trial of people with Parkinson\u0027s disease.", "to": "Parkinson\u0027s disease"}, {"from": "Clinical trial", "title": "The clinical trial assessed the safety, tolerability, and behavior of nilotinib in people with Parkinson\u0027s disease.", "to": "Nilotinib"}, {"from": "Clinical trial", "title": "The clinical trial investigated the impact of nilotinib on certain substances that scientists think could be useful biomarkers for Parkinson\u0027s disease.", "to": "Biomarkers for tracking disease progress and the effectiveness of therapies"}, {"from": "Biomarkers for tracking disease progress and the effectiveness of therapies", "title": "The biomarkers include products of dopamine metabolism, levels of alpha-synuclein, and tau, which are measured by sampling cerebrospinal fluid through a lumbar puncture.", "to": "Products of dopamine metabolism, alpha-synuclein, and tau"}, {"from": "Clinical trial", "title": "The clinical trial tracked changes in motor and nonmotor Parkinson\u0027s symptoms at various stages during the 15-month trial.", "to": "Motor and nonmotor Parkinson\u0027s symptoms"}, {"from": "Parkinson\u0027s disease", "title": "Parkinson\u0027s disease arises when brain cells that produce dopamine stop working and die, leading to motor and nonmotor symptoms such as tremor, slowness, stiffness, balance difficulties, depression, memory problems, emotional changes, and constipation.", "to": "Motor and nonmotor Parkinson\u0027s symptoms"}, {"from": "Parkinson\u0027s disease", "title": "According to the Parkinson\u0027s Foundation, Parkinson\u0027s disease affects a significant number of people in the United States, with a higher incidence in males than females.", "to": "Around 60,000 people receive a diagnosis of Parkinson\u0027s per year in the United States, where nearly 1 million are living with the disease. Parkinson\u0027s usually affects people after the age of 60 and is more common in males than females."}, {"from": "Parkinson\u0027s disease", "title": "One of the biological hallmarks of Parkinson\u0027s disease is the accumulation of badly-folded alpha-synuclein protein in the affected areas of the brain.", "to": "Accumulation of badly-folded alpha-synuclein protein"}, {"from": "FDA", "title": "The FDA has approved nilotinib for the treatment of a particular type of myeloid leukemia in children.", "to": "Nilotinib"}, {"from": "Moussa and colleagues", "title": "Moussa and colleagues are interested in the potential for repurposing nilotinib for use in the treatment of Parkinson\u0027s disease.", "to": "Nilotinib"}, {"from": "Moussa and colleagues", "title": "Moussa and colleagues cite research reports of how low doses of nilotinib entered the brain and reduced alpha-synuclein and tau proteins in animal models of neurodegeneration.", "to": "Animal models of neurodegeneration"}, {"from": "Moussa and colleagues", "title": "Moussa and colleagues refer to another study that found that nilotinib may increase dopamine metabolism and potentially treat motor and nonmotor symptoms of Parkinson\u0027s disease.", "to": "Another study"}, {"from": "Clinical trial", "title": "The clinical trial randomly assigned 75 participants with moderately advanced Parkinson\u0027s disease to three groups.", "to": "Participants with moderately advanced Parkinson\u0027s disease"}, {"from": "Clinical trial", "title": "The clinical trial randomly assigned participants to three groups: one group received 150 milligrams (mg) of nilotinib per day, another received 300 mg of nilotinib per day, and the third received a placebo.", "to": "Three groups"}, {"from": "Clinical trial", "title": "The clinical trial administered 150 milligrams (mg) and 300 mg of nilotinib per day to two of the groups.", "to": "150 milligrams (mg) and 300 mg of nilotinib per day"}, {"from": "Clinical trial", "title": "The clinical trial administered a placebo to one of the groups.", "to": "Placebo"}, {"from": "Clinical trial", "title": "The participants took the daily oral dose of drug or placebo for 12 months.", "to": "12 months"}, {"from": "Clinical trial", "title": "After the 12-month trial period, the participants underwent a washout period with no nilotinib or placebo for 3 months.", "to": "3 months"}, {"from": "Clinical trial", "title": "The clinical trial was double-blinded, meaning that neither the participants nor the administrators knew which individuals received the placebo and which received the active drug until the end of each participant\u0027s trial period.", "to": "Double-blinding"}, {"from": "Results", "title": "The results showed that doses of 150 mg and 300 mg of nilotinib were reasonably safe.", "to": "Reasonably safe"}, {"from": "Results", "title": "The results showed that people in the two nilotinib groups experienced more severe side effects than those in the placebo group.", "to": "More severe side effects"}, {"from": "Nilotinib", "title": "Nilotinib blocks Abl tyrosine kinase, which is a protein essential for cell functioning.", "to": "Abl tyrosine kinase"}, {"from": "FDA", "title": "The FDA requires nilotinib to carry a black box warning about the risk of sudden death due to Abl inhibition.", "to": "Black box warning"}, {"from": "Results", "title": "The results showed that at lower doses, nilotinib does not seem to cause Abl inhibition, suggesting it shouldn\u0027t have the same safety concerns as might be the case at higher doses.", "to": "Nilotinib does not seem to cause Abl inhibition"}, {"from": "Results", "title": "The results showed that participants who took nilotinib had lower levels of alpha-synuclein and tau.", "to": "Lower levels of alpha-synuclein and tau"}, {"from": "Results", "title": "The results showed that participants who took nilotinib had higher levels of dopamine metabolites.", "to": "Higher levels of dopamine metabolites"}, {"from": "Results", "title": "The results suggest that nilotinib was able to slow the progression of nonmotor symptoms compared with the placebo.", "to": "Slowed progression"}, {"from": "Results", "title": "The results showed overall improvements in motor symptoms in the participants who took nilotinib compared with the placebo group.", "to": "Improvements"}, {"from": "Fernando L. Pagan", "title": "Fernando L. Pagan was the principal trial investigator and first author of the study.", "to": "Clinical trial"}, {"from": "Fernando L. Pagan", "title": "Fernando L. Pagan is also professor of neurology at GUMC and medical director of its Translational Neurotherapeutics Program.", "to": "Translational Neurotherapeutics Program"}, {"from": "Results", "title": "The nilotinib groups also scored higher on quality of life measures during the trial.", "to": "Higher scores"}, {"from": "Fernando L. Pagan", "title": "Researchers need to carry out more extensive studies in more diverse populations to confirm these important observations suggesting that nilotinib stabilized the disease \u2013 a potential disease-modifying effect that they haven\u2019t observed with any other agents.", "to": "Important observations"}, {"from": "acute myeloid leukemia (AML)", "title": "AML is a specific type of cancer.", "to": "AML"}, {"from": "acute myeloid leukemia (AML)", "title": "AML starts in bone marrow.", "to": "bone marrow"}, {"from": "acute myeloid leukemia (AML)", "title": "AML soon spreads into the bloodstream.", "to": "bloodstream"}, {"from": "acute myeloid leukemia (AML)", "title": "In some cases, AML can also spread to other parts of the body, such as the liver, spleen, lymph system, testicles, brain, and spinal cord.", "to": "liver, spleen, lymph system, testicles, brain, and spinal cord"}, {"from": "acute myeloid leukemia (AML)", "title": "MTF2 is a biomarker for AML diagnosis.", "to": "MTF2"}, {"from": "MTF2", "title": "MTF2\u0027s role in cancer is analyzed through gene expression analysis.", "to": "gene expression analysis"}, {"from": "MTF2", "title": "Samples taken from people with AML are used to analyze MTF2.", "to": "samples taken from people with AML"}, {"from": "gene expression analysis", "title": "Gene expression analysis involves placing chemical tags.", "to": "chemical tags placement"}, {"from": "gene expression analysis", "title": "Gene expression analysis is performed using mouse models of AML.", "to": "mouse models of AML"}, {"from": "gene expression analysis", "title": "Gene expression analysis leads to the use of MDM2 blockers.", "to": "MDM2 blockers"}, {"from": "gene expression analysis", "title": "Gene expression analysis is used in conjunction with chemotherapy.", "to": "chemotherapy"}, {"from": "chemotherapy", "title": "Chemotherapy triggers a cell death pathway.", "to": "cell death pathway"}, {"from": "chemotherapy", "title": "Chemotherapy is used in mouse models of AML.", "to": "mouse models of AML"}, {"from": "mouse models of AML", "title": "Mouse models of AML are used for AML diagnosis.", "to": "acute myeloid leukemia (AML)"}, {"from": "mouse models of AML", "title": "Mouse models of AML involve bone marrow.", "to": "bone marrow"}, {"from": "mouse models of AML", "title": "Mouse models of AML involve the bloodstream.", "to": "bloodstream"}, {"from": "mouse models of AML", "title": "Mouse models of AML use chemoresistant AML cells from humans.", "to": "chemoresistant AML cells from humans"}, {"from": "chemotherapy", "title": "Chemotherapy is used with MDM2 blockers.", "to": "MDM2 blockers"}, {"from": "MDM2 blockers", "title": "MDM2 blockers are used in mouse models of AML.", "to": "mouse models of AML"}, {"from": "N/A", "title": "The new research is a study on the health effects of e-cigarettes, but it is not specifically about cancer diagnosis methods.", "to": "New research on e-cigarettes\u0027 health effects"}, {"from": "N/A", "title": "The new research exposes mice to e-cigarettes with and without nicotine, indicating that nicotine is a drug being studied.", "to": "Nicotine"}, {"from": "N/A", "title": "The new research uses Electronic Nicotine Delivery Systems (ENDS), which include e-cigarettes, as a device to study its effects on mice.", "to": "Electronic Nicotine Delivery Systems (ENDS), e-cigarettes"}, {"from": "N/A", "title": "The new research uses aerosolization technology to study its effects on mice.", "to": "Aerosolization technology"}, {"from": "Heart", "title": "The new research uses Electrocardiogram (ECG) as a method to diagnose the effects of e-cigarettes on the heart.", "to": "Electrocardiogram (ECG)"}, {"from": "Heart", "title": "The new research identifies bradycardia, increased blood pressure, and aldehydes as biomarkers for diagnosing the effects of e-cigarettes on the heart.", "to": "Bradycardia, increased blood pressure, aldehydes"}, {"from": "Heart", "title": "The new research implants ECG transmitters in mice to diagnose the effects of e-cigarettes on the heart.", "to": "ECG transmitters"}, {"from": "cancer", "title": "The text mentions a new study about the potential risks of a gluten-free diet, which is relevant to cancer diagnosis and treatment, as it is a diet followed by people with celiac disease, an autoimmune condition where gluten intake leads to intestinal damage. However, the text does not provide specific details about the new research being conducted on cancer diagnosis methods.", "to": "new research of cancer diagnosis method"}, {"from": "gluten-free diet", "title": "The text mentions that a gluten-free diet excludes foods that contain gluten, a protein found in wheat, barley, and rye, as well as their byproducts. However, there is no direct relationship between a gluten-free diet and tissue used for cancer diagnosis.", "to": "tissue used for cancer diagnosis"}, {"from": "gluten-free diet", "title": "The text mentions that a gluten-free diet is the only treatment for celiac disease, an autoimmune condition where gluten intake leads to intestinal damage. However, there is no direct relationship between a gluten-free diet and tissue affected by cancer.", "to": "tissue affected by cancer"}, {"from": "gluten-free diet", "title": "The text mentions that a gluten-free diet may raise the risk of exposure to arsenic and mercury, which have been associated with increased risk of cancer. However, there is no direct relationship between a gluten-free diet and biomarkers for cancer diagnosis.", "to": "biomarker for cancer diagnosis"}, {"from": "gluten-free diet", "title": "The text does not mention any relationship between a gluten-free diet and drugs used for cancer diagnosis.", "to": "drugs"}, {"from": "gluten-free diet", "title": "The text does not mention any relationship between a gluten-free diet and a particular method used for cancer diagnosis.", "to": "cancer diagnosis method"}, {"from": "gluten-free diet", "title": "The text does not mention any relationship between a gluten-free diet and a device or tool used for cancer diagnosis.", "to": "cancer diagnosis device/tool"}, {"from": "gluten-free diet", "title": "The text does not mention any relationship between a gluten-free diet and a particular technology used for cancer diagnosis.", "to": "cancer diagnosis technology"}, {"from": "gluten-free diet", "title": "The text does not mention any specific type of cancer in relation to a gluten-free diet.", "to": "cancer type"}, {"from": "gluten-free diet", "title": "The text mentions that a gluten-free diet is the only treatment for celiac disease, an autoimmune condition where gluten intake leads to intestinal damage. However, there is no direct relationship between a gluten-free diet and cancer in general.", "to": "cancer"}, {"from": "rice flour", "title": "The text mentions that rice flour is a common substitute for gluten in many gluten-free products. However, there is no direct relationship between rice flour and tissue used for cancer diagnosis.", "to": "tissue used for cancer diagnosis"}, {"from": "rice flour", "title": "The text does not mention any relationship between rice flour and tissue affected by cancer.", "to": "tissue affected by cancer"}, {"from": "rice flour", "title": "The text mentions that rice can bioaccumulate arsenic, mercury, and other potentially harmful toxic metals from water, soil, or fertilizers. Exposure to these metals has been associated with increased risk of cancer. However, there is no direct relationship between rice flour and biomarkers for cancer diagnosis.", "to": "biomarker for cancer diagnosis"}, {"from": "rice flour", "title": "The text does not mention any relationship between rice flour and drugs used for cancer diagnosis.", "to": "drugs"}, {"from": "rice flour", "title": "The text does not mention any relationship between rice flour and a particular method used for cancer diagnosis.", "to": "cancer diagnosis method"}, {"from": "rice flour", "title": "The text does not mention any relationship between rice flour and a device or tool used for cancer diagnosis.", "to": "cancer diagnosis device/tool"}, {"from": "rice flour", "title": "The text does not mention any relationship between rice flour and a particular technology used for cancer diagnosis.", "to": "cancer diagnosis technology"}, {"from": "rice flour", "title": "The text does not mention any specific type of cancer in relation to rice flour.", "to": "cancer type"}, {"from": "rice flour", "title": "The text mentions that rice can bioaccumulate arsenic, mercury, and other potentially harmful toxic metals from water, soil, or fertilizers. Exposure to these metals has been associated with increased risk of cancer. However, there is no direct relationship between rice flour and cancer in general.", "to": "cancer"}, {"from": "arsenic", "title": "The text mentions that arsenic has been associated with increased risk of cancer. However, arsenic is not a biomarker for cancer diagnosis.", "to": "biomarker for cancer diagnosis"}, {"from": "mercury", "title": "The text mentions that mercury has been associated with increased risk of cancer. However, mercury is not a biomarker for cancer diagnosis.", "to": "biomarker for cancer diagnosis"}, {"from": "arsenic", "title": "The text does not mention any relationship between arsenic and a device or tool used for cancer diagnosis.", "to": "cancer diagnosis device/tool"}, {"from": "mercury", "title": "The text does not mention any relationship between mercury and a device or tool used for cancer diagnosis.", "to": "cancer diagnosis device/tool"}, {"from": "arsenic", "title": "The text does not mention any relationship between arsenic and a particular method used for cancer diagnosis.", "to": "cancer diagnosis method"}, {"from": "mercury", "title": "The text does not mention any relationship between mercury and a particular method used for cancer diagnosis.", "to": "cancer diagnosis method"}, {"from": "arsenic", "title": "The text does not mention any relationship between arsenic and a particular technology used for cancer diagnosis.", "to": "cancer diagnosis technology"}, {"from": "mercury", "title": "The text does not mention any relationship between mercury and a particular technology used for cancer diagnosis.", "to": "cancer diagnosis technology"}, {"from": "arsenic", "title": "The text does not mention any specific type of cancer in relation to arsenic.", "to": "cancer type"}, {"from": "mercury", "title": "The text does not mention any specific type of cancer in relation to mercury.", "to": "cancer type"}, {"from": "arsenic", "title": "The text mentions that arsenic has been associated with increased risk of cancer. However, there is no direct relationship between arsenic and cancer in general.", "to": "cancer"}, {"from": "mercury", "title": "The text mentions that mercury has been associated with increased risk of cancer. However, there is no direct relationship between mercury and cancer in general.", "to": "cancer"}, {"from": "Cancer", "title": "Cancer diagnosis can be done by observing the immune reaction triggered by the body against cancer.", "to": "Immune reaction triggered by the body"}, {"from": "Cancer", "title": "Cancer is a condition where the body\u0027s own cells or tissues are perceived as harmful, leading to an immune reaction.", "to": "Tissue affected by cancer"}, {"from": "C-reactive protein (CRP)", "title": "C-reactive protein (CRP) is a biomarker used to test for inflammation, which is often present in cancer.", "to": "Cancer diagnosis"}, {"from": "Nonsteroidal anti-inflammatory drugs (NSAIDs)", "title": "Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to relieve pain, swelling, fever, and other symptoms of inflammation.", "to": "Treatment for Inflammation"}, {"from": "Corticosteroids", "title": "Corticosteroids are used to manage a range of conditions, including arthritis, dermatitis, and asthma, by affecting various mechanisms involved in inflammation.", "to": "Treatment for Inflammation"}, {"from": "Immunosuppressant drugs", "title": "Immunosuppressant drugs are used to repress the body\u2019s immune reactions, helping relieve symptoms of rheumatoid arthritis, psoriasis, and other similar autoimmune reactions.", "to": "Treatment for Inflammation"}, {"from": "Olive oil, high fiber foods, tomatoes, nuts, leafy greens, fatty fish, fruit", "title": "Foods like olive oil, high fiber foods, tomatoes, nuts, leafy greens, fatty fish, and fruit are part of an anti-inflammatory diet, which can help prevent inflammation from getting worse.", "to": "Anti-inflammatory diet"}, {"from": "Fried foods, highly processed foods, foods and drinks with added sugar, red meat, unhealthful fats", "title": "Fried foods, highly processed foods, foods and drinks with added sugar, red meat, and unhealthful fats can aggravate inflammation.", "to": "Diet that aggravates inflammation"}, {"from": "smart toilet", "title": "The smart toilet has an algorithm that can detect abnormal urine flow rate, stream time, and volume which could be useful for flagging prostate problems in men.", "to": "prostate cancer"}, {"from": "urinalysis strips", "title": "The smart toilet uses urinalysis strips to detect 10 different markers including the number of white blood cells and the levels of specific proteins in the urine. These biomarkers can provide early warnings of diseases such as kidney infections and bladder cancer.", "to": "biomarkers"}, {"from": "smart toilet", "title": "The smart toilet can detect blood in someone\u0027s urine which could indicate a problem in the urinary tract.", "to": "urinary tract"}, {"from": "smart toilet", "title": "The smart toilet captures and analyzes data from both urine and feces for disease detection.", "to": "feces, urine"}, {"from": "machine learning algorithms", "title": "The smart toilet uses machine learning algorithms to gauge the consistency of fecal matter from the images and classify it according to the Bristol stool chart.", "to": "gauging the consistency of fecal matter from the images"}, {"from": "smart toilet", "title": "The smart toilet\u0027s software can identify color changes in urine using urinalysis strips and detect 10 different markers including the number of white blood cells and the levels of specific proteins in the urine. These biomarkers can provide early warnings of diseases such as gut inflammation and a lack of dietary fiber.", "to": "gut, intestines"}, {"from": "cancer", "title": "Chlorogenic acids, a group of antioxidant compounds found in green coffee bean extract, are believed to be responsible for potential health benefits such as improving blood pressure and cholesterol levels, which may be associated with cancer prevention or treatment.", "to": "chlorogenic acids"}, {"from": "cancer", "title": "Caffeine, found in green coffee bean extract, may help promote weight loss, which could potentially impact cancer prevention or treatment.", "to": "caffeine"}, {"from": "cancer", "title": "Green coffee bean extract, which contains chlorogenic acids and caffeine, may have potential health benefits such as improving blood pressure and cholesterol levels, promoting weight loss, and providing antioxidants, which could impact cancer prevention or treatment.", "to": "green coffee bean extract"}, {"from": "cancer", "title": "Green coffee bean extract may help protect the heart, which could be relevant in cancer treatment due to potential cardiotoxic effects of certain cancer therapies.", "to": "heart"}, {"from": "cancer", "title": "Green coffee bean extract may help protect the liver, which could be relevant in cancer treatment due to potential hepatotoxic effects of certain cancer therapies.", "to": "liver"}, {"from": "chlorogenic acid", "title": "Chlorogenic acid is both a cancer diagnosis method and a biomarker for cancer diagnosis, as it may help lower blood sugar levels and reduce insulin spikes by reducing carbohydrate absorption in the digestive tract, and it may also boost fat metabolism, lower cholesterol and triglyceride levels, and improve obesity-related hormone levels.", "to": "chlorogenic acid"}, {"from": "chlorogenic acid", "title": "Chlorogenic acid is used in cancer diagnosis by reducing carbohydrate absorption in the digestive tract.", "to": "digestive tract"}, {"from": "chlorogenic acid", "title": "Chlorogenic acid may help protect the liver, which could be relevant in cancer treatment due to potential hepatotoxic effects of certain cancer therapies.", "to": "liver"}, {"from": "chlorogenic acid", "title": "Chlorogenic acid may help protect the heart, which could be relevant in cancer treatment due to potential cardiotoxic effects of certain cancer therapies.", "to": "heart"}, {"from": "green coffee bean extract", "title": "Green coffee bean extract is a cancer diagnosis method and a drug, as it contains chlorogenic acids and caffeine, which may have potential health benefits such as improving blood pressure and cholesterol levels, promoting weight loss, and providing antioxidants.", "to": "green coffee bean extract"}, {"from": "green coffee bean extract", "title": "Green coffee bean extract is used in cancer diagnosis by reducing carbohydrate absorption in the digestive tract.", "to": "digestive tract"}, {"from": "green coffee bean extract", "title": "Green coffee bean extract may help protect the liver, which could be relevant in cancer treatment due to potential hepatotoxic effects of certain cancer therapies.", "to": "liver"}, {"from": "green coffee bean extract", "title": "Green coffee bean extract may help protect the heart, which could be relevant in cancer treatment due to potential cardiotoxic effects of certain cancer therapies.", "to": "heart"}, {"from": "digestive tract", "title": "Green coffee bean extract and chlorogenic acid may help protect the liver, which could be relevant in cancer treatment due to potential hepatotoxic effects of certain cancer therapies.", "to": "liver"}, {"from": "digestive tract", "title": "Green coffee bean extract and chlorogenic acid may help protect the heart, which could be relevant in cancer treatment due to potential cardiotoxic effects of certain cancer therapies.", "to": "heart"}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {
    "configure": {
        "enabled": false
    },
    "edges": {
        "color": {
            "inherit": true
        },
        "smooth": {
            "enabled": true,
            "type": "dynamic"
        }
    },
    "interaction": {
        "dragNodes": true,
        "hideEdgesOnDrag": false,
        "hideNodesOnDrag": false
    },
    "physics": {
        "enabled": true,
        "stabilization": {
            "enabled": true,
            "fit": true,
            "iterations": 1000,
            "onlyDynamicEdges": false,
            "updateInterval": 50
        }
    }
};

                  


                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  
                      network.on("stabilizationProgress", function(params) {
                          document.getElementById('loadingBar').removeAttribute("style");
                          var maxWidth = 496;
                          var minWidth = 20;
                          var widthFactor = params.iterations/params.total;
                          var width = Math.max(minWidth,maxWidth * widthFactor);
                          document.getElementById('bar').style.width = width + 'px';
                          document.getElementById('text').innerHTML = Math.round(widthFactor*100) + '%';
                      });
                      network.once("stabilizationIterationsDone", function() {
                          document.getElementById('text').innerHTML = '100%';
                          document.getElementById('bar').style.width = '496px';
                          document.getElementById('loadingBar').style.opacity = 0;
                          // really clean the dom element
                          setTimeout(function () {document.getElementById('loadingBar').style.display = 'none';}, 500);
                      });
                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html><div style="position: absolute; bottom: 10px; left: 10px; background: white; padding: 10px; border: 1px solid black; z-index: 1000;"><strong>Legend:</strong><br><div style="color: #1f77b4;"> Cancer Type</div><div style="color: #ff7f0e;"> Cancer</div><div style="color: #2ca02c;"> Biomarker for Cancer Diagnosis</div><div style="color: #d62728;"> Tissue used for cancer diagnosis</div><div style="color: #9467bd;"> Tissue affected by cancer</div><div style="color: #8c564b;"> Cancer Diagnosis Method</div><div style="color: #e377c2;"> Cancer Diagnosis Device/Tool</div><div style="color: #7f7f7f;"> Cancer Diagnosis Technology</div><div style="color: #bcbd22;"> Drugs</div><div style="color: #17becf;"> New Research of Cancer Diagnosis Method</div></div>